SCHEMBL13759367

SCHEMBL13759367

CCNc1cc(N(CN(CC)c2cc(N/N=C/c3cccc(C)c3)nc(OCCNCCO)n2)/N=C/c2cccc(C)c2)nc(OCCNC)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FES P07332 1/20 0.37
▸ FER P16591 1/20 0.37
▸ TYK2 P29597 1/20 0.37
▸ FRK P42685 1/20 0.37
▸ SYK P43405 1/20 0.37
▸ CAMK1D Q8IU85 1/20 0.37
▸ IRAK4 Q9NWZ3 1/20 0.37
▸ PIKFYVE Q9Y2I7 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.33
▸ MAPT P10636 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ XBP1 P17861 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL429145 0.83 PIKFYVE (0.47) FESFERTYK2FRKSYK
SCHEMBL429146 0.83 PIKFYVE (0.47) FESFERTYK2FRKSYK
SCHEMBL13759169 0.79 PIKFYVE (0.43) FESFERTYK2FRKSYK
SCHEMBL13759268 0.78 PIKFYVE (0.46) FESFERTYK2FRKSYK
SCHEMBL427219 0.76 FES (0.49) FESFERTYK2FRKSYK
SCHEMBL427218 0.76 FES (0.49) FESFERTYK2FRKSYK
SCHEMBL13759185 0.76 PIKFYVE (0.46) FESFERTYK2FRKSYK
SCHEMBL424843 0.72 PIKFYVE (0.43) FESFERTYK2FRKSYK
SCHEMBL424842 0.72 PIKFYVE (0.43) FESFERTYK2FRKSYK
SCHEMBL423017 0.72 PIKFYVE (0.45) FESFERTYK2FRKSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009100406-A2 TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS SYNTA PHARMACEUTICALS CORP. (US) 2009-08-13 — — WO disclosed
Send feedback